JRE #2461 - Robert F. Kennedy Jr. · Aired Feb 27, 2026
Claim summary · not a verbatim quotation
Big Pharma pays $4.5 billion in fines per year, which they consider a cost of doing business.
The finding
What the evidence shows
The framing holds up better than the figure. Public Citizen counted $62.3 billion in penalties against drug manufacturers across 482 cases from 1991 to 2021, which averages closer to $2 billion a year, though global regulatory fines hit $11.2 billion in 2025 alone. The cost of doing business point is the part with real support: those penalties work out to about $1 for every $31 in profit.
Read the supporting source · www.citizen.org ↗Quick answer & review status
Quick answer
Is it true that Big Pharma pays $4.5 billion in fines per year, which they consider a cost of doing business?
Partly. The claim stretches what the evidence shows. The framing holds up better than the figure. 2 billion in 2025 alone. It was said on JRE #2461 - Robert F. Kennedy Jr., aired Feb 27, 2026, at 2:50:00. We haven't independently confirmed who said it. The supporting source is citizen.org, linked below.
The context belongs here.
No separately verified on-air correction is recorded for this check. That is not a claim that nobody corrected it.
- Attribution
- Not independently confirmed in this record
- Editorial context review
- Not recorded; generated finding
- Coverage
- One selected claim from the episode
Revisions to this check
No dated revision is recorded here. Older checks may predate this log.
Challenge this finding or add context →Keep the evidence coming.
Follow new checks in your RSS reader, or catch up with the weekly briefing on the site.
Email signup is currently unavailable.
Prefer to catch up here? Read the weekly briefing.